RESEARCH ARTICLE


Protein Misfolding Diseases



Vittorio Bellotti*, Monica Stoppini
Department of Biochemistry, University of Pavia and Laboratory of Biotechnology, Fondazione IRCCS - Policlinico San Matteo, via Taramelli 3b. I-27100 Pavia, Italy


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 184
Abstract HTML Views: 316
PDF Downloads: 284
Total Views/Downloads: 784
Unique Statistics:

Full-Text HTML Views: 132
Abstract HTML Views: 243
PDF Downloads: 226
Total Views/Downloads: 601



© 2009 Bellotti and Stoppini

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Biochemistry, University of Pavia, via Taramelli 3b -27100 Pavia, Italy; Tel: 0039-0382- 987232; Fax: 0039-0382-423108; E-mail: vbellot@unipv.it


Abstract

Diseases caused by protein misfolding are an emerging pathologic category that are thought to share some basic common mechanisms and display impressive heterogeneity in terms of tissue involvement, age of onset and clinical features. The growing recognition of the impact that protein misfolding has on human diseases is certainly related to the phenomenon of population aging and the expansion of the population in which these diseases are more frequent, but it is also based on a scientific revolution that looks at protein dynamics and relates these data to their potential pathologic implications. The multidisciplinary exchange of knowledge between experts in apparently unrelated diseases, such as sickle cell anemia and Alzheimer’s disease, has helped clarify the pathogenesis of these and many other diseases. The quick expansion of knowledge on the mechanisms of these diseases is priming pharmaceutical research that is now providing the first prototype drugs.

Keywords: Protein misfolding disease, amyloid disease, pathogenesis, protein aggregation and cytotoxicity.